Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

rituximab Injection [Rituxan]

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
&NA; The advent of monoclonal antibody biosimilar products has stimulated the development of analytical methods that can better… Expand
  • figure 1
  • figure 2
Is this relevant?
2018
2018
This report assesses the observed risk of PML in patients treated with the anti-CD20 monoclonal antibody rituximab in the… Expand
  • figure 1
  • figure 2
  • table 2
Is this relevant?
2017
2017
The viscosity of concentrated aqueous solutions of 3 clinical monoclonal antibodies (mAbs), Erbitux®, Herceptin®, and Rituxan… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2014
2014
Following the successes of monoclonal antibody immunotherapies (trastuzumab (Herceptin®) and rituximab (Rituxan®)) and the first… Expand
  • figure 1
  • figure 2
Is this relevant?
Review
2014
Review
2014
A paradigm shift in the treatment of chronic lymphocytic leukemia (CLL) has taken place over the past decade, as therapies have… Expand
Is this relevant?
2010
2010
Multifocal motor neuropathy (MMN) is an acquired demyelinating motor neuropathy. Intravenous immunoglobulin (IVIg) has been found… Expand
Is this relevant?
2008
2008
Goals of workTargeted monoclonal antibodies (MoAbs) have become a promising treatment option for patients with cancer. However… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 1
Is this relevant?
Review
2006
Review
2006
  • R. Dillman
  • Clinical and Experimental Medicine
  • 2006
  • Corpus ID: 14035419
CD20 has proven to be an excellent target for the treatment of B-cell lymphoma, first for the chimeric monoclonal antibody… Expand
  • table 1
  • figure 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2001
2001
The objective of this multiinstitutional study was to evaluate the safety and efficacy of rituximab at standard four weekly doses… Expand
Is this relevant?
Highly Cited
2000
Highly Cited
2000
Inhibitory receptors have been proposed to modulate the in vivo cytotoxic response against tumor targets for both spontaneous and… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?